Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Henry Khederian

What's Going On With Coya Therapeutics Stock?

Sonnet BioTherapeutics Inc.

Shares of Coya Therapeutics Inc (NASDAQ:COYA) are trading higher Monday morning after the company provided an update regarding the development of a new treatment for Amyotrophic Lateral Sclerosis (ALS).

What To Know: The Houston-based clinical-stage biotechnology company is trending across social media platforms after revealing that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for COYA 302.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.